Supplemental material
Pharmacogenomics
Volume 24, 2023 - Issue 11
Research Article
Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism
Estee Y Cramer1 Center for Global Health & Diseases, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA;2 Department of Biostatistics & Epidemiology, School of Public Health & Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA
https://orcid.org/0000-0003-1373-3177View further author information
https://orcid.org/0000-0003-1373-3177View further author information, , , Andrea Gaedigk5 Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy Research Institute (CMRI), Kansas City, MO 64108, USAhttps://orcid.org/0000-0001-6968-1893View further author information
https://orcid.org/0000-0001-6968-1893View further author information, , Rajeev K Mehlotra1 Center for Global Health & Diseases, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USACorrespondence[email protected]
https://orcid.org/0000-0003-4205-750XView further author information
https://orcid.org/0000-0003-4205-750XView further author information, Scott M Williams3 Population & Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USACorrespondence[email protected]
https://orcid.org/0000-0002-4835-9544View further author information
https://orcid.org/0000-0002-4835-9544View further author information & Peter A Zimmerman1 Center for Global Health & Diseases, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USACorrespondence[email protected]
https://orcid.org/0000-0002-5349-4513View further author information
https://orcid.org/0000-0002-5349-4513View further author information show all